<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2993">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04539821</url>
  </required_header>
  <id_info>
    <org_study_id>C19 20-397</org_study_id>
    <nct_id>NCT04539821</nct_id>
  </id_info>
  <brief_title>Virtual Pain Care Management (COVID-19)</brief_title>
  <acronym>VCPM</acronym>
  <official_title>Virtual Pain Care for High Risk Veterans on Opioids During COVID19 (and Beyond)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The COVID-19 pandemic is exacerbating the challenges faced by Veterans at risk of opioid
      overdose including Veterans prescribed moderate-to-high dose long-term opioid therapy (LTOT)
      whose usual treatment resources and coping strategies may be inaccessible. This project
      combines established VA care components to deploy and evaluate virtual models of care for
      Veterans on high-risk LTOT to meet the dual challenges of maintaining social distancing and
      delivery high quality care.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This single-arm feasibility study will be conducted in two VA sites.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the percent of patients who agree to Buprenorphine transfer</measure>
    <time_frame>30 days</time_frame>
    <description>Although the project will use shared decision-making with Veterans, the percent of patients who agree to transfer will provide a realistic indicator of overall feasibility/acceptability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>percent of complete tapering or BUP transition</measure>
    <time_frame>60 days</time_frame>
    <description>overall measure of engagement</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>VCPM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>VCPM is a multi-component intervention consisting of already-established care processes and materials. First, the patient is mailed or emailed (based on their preference) an informational packet prior to intake appointment. Second, using the collaborative medication management model established in VHA,3 the intake appointment is led by the CPS using a standardized intake evaluation. The CPS and physician design a plan presented to the patient. If BUP switch is offered and accepted, the physician completes additional brief evaluations, including a history, medication review, treatment planning, and discussion of other VCPM components, using two-way audio-video visits (with telephone as a back-up).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VCPM</intervention_name>
    <description>VCPM is a multi-component intervention consisting of already-established care processes and materials.</description>
    <arm_group_label>VCPM</arm_group_label>
    <other_name>Virtual Chronic Pain Management</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible participants must currently receive LTOT for chronic pain at 50 mg morphine
             equivalent daily dose

        Exclusion Criteria:

        Exclusion criteria at baseline are:

          -  dementia diagnosis or moderate-severe cognitive impairment

          -  unstable or severe untreated psychiatric disorder or medical disease that requires
             hospitalization

          -  documentation of suspected controlled substance diversion

          -  inability to communicate by phone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brent Adams Moore, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Connecticut Healthcare System West Haven Campus, West Haven, CT</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samara Zuniga, BA</last_name>
    <phone>(203) 932-5711</phone>
    <email>Samara.Zuniga@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brent A Moore, PhD</last_name>
    <phone>(203) 932-5711</phone>
    <phone_ext>2587</phone_ext>
    <email>brent.moore@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rocky Mountain Regional VA Medical Center, Aurora, CO</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Joseph W Frank, MD MPH</last_name>
      <phone>720-857-2784</phone>
      <email>joseph.frank2@va.gov</email>
    </contact>
    <investigator>
      <last_name>Joseph W Frank, MD MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Connecticut Healthcare System West Haven Campus, West Haven, CT</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Samara Zuniga, BA</last_name>
      <phone>(203) 932-5711</phone>
      <email>Samara.Zuniga@va.gov</email>
    </contact>
    <investigator>
      <last_name>Brent Adams Moore, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 3, 2020</study_first_submitted>
  <study_first_submitted_qc>September 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2020</study_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>buprenorphine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

